Loading
EH
Epsilon Healthcare Limited Stock: price and insider trades · Australia
2 insiders bought €18k of shares over the last 90 days, the latest filed 17 Sept 2026.
Epsilon Healthcare Limited: what insiders have been doing
Epsilon Healthcare Limited is a listed company. Its insiders report their share dealings to ASX. From 18 October 2025 to 18 October 2026, the disclosure feed for Epsilon Healthcare Limited logged 4 filings by 3 insiders.
The flow runs one way only: 2 insiders bought (3 purchases totalling €36k) and nobody sold on the market. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 2 senior executives. At €18k, the purchase published on 6 July 2026 by Zoe Hutchings is the largest of the period (0.27% of market cap).
Across the 2,535 companies tracked on its exchange, the median is 3 filings; at 4 filings, this issuer sits above that mark. Looking back to 2026, when coverage begins, insiders filed 3 purchases and no sales.
The last purchase on record was published on 17 September 2026, which is 31 days ago.
Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
4
Thresholds
n/a
Buy Volume
€36,124
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleZoe Hutchings2 buys
Alan Preston Beasley1 buy
Since the insiders bought
- +0.0%Entry A$0.03 · Close at T+30 A$0.03
- +4.5%Entry A$0.02 · Close 16 Oct 2026 A$0.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 17,477 of 24,148 companies
36.7
score / 100
Value11
Quality63
FCF yld-30%
Earn yld-12%
EV/EBITDA·
ROE50%
Gross mgn61%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
A$0.03
Analyst consensus
Income statement
RevenueA$9.4M
Gross profitA$5.8M61% margin
EBITDA-A$987.1k-11% margin
Net income-A$1.3M0.5% margin
Valuation
P/Book2.8x
Beta0.75
Balance sheet & cash
Market capA$10.9M
Total debtA$10.4M
Free Cash Flow-A$3.3M
Debt / Equity224%
Profitability & ownership
ROE50.3%
ROA-5.3%
% insiders49.4%
% institutions0.0%
Last declaration on 17 September 2026
Declarations4 total
ShareASXISIN AU0000137598ASX:2924-03136632-2A1697721
Canonical exit: 16 Dec 2026 (T+90)
1,200,000 shares@ A$0.02420.27% mcap100.0% of flowShareASXISIN AU0000137598ASX:2924-03134159-2A1696529
Canonical exit: 9 Dec 2026 (T+90)
1,500,000 shares@ A$0.020.27% mcap100.0% of flowShareASXISIN AU0000137598ASX:2924-03108320-2A1682954
Canonical exit: 1 Oct 2026 (T+90)
4 of 4 declarations
About Epsilon Healthcare Limited
Epsilon Healthcare Limited is a company listed on the XASX, specializing in the healthcare sector.
